CYP27A1 and invasive ductal breast carcinoma: The loss of function of the enzyme CYP27A1 has been reported in certain types of cancer, such as bladder urothelial carcinoma, breast invasive ductal carcinoma, renal clear cell carcinoma, prostate adenocarcinoma and cutaneous melanoma [34].